MALVERN, Pa.–(BUSINESS WIRE)–NexEos Bio Vision Health (“NexEos”), a clinical-stage biopharmaceutical company developing novel therapies and diagnostics targeting eosinophil-mediated diseases, today announced that the U.S. Food and Drug Administration…
Author: Business Wire
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vyome announces the publication of positive preclinical results in uveitis, addressing a $3B potential market opportunity
National Vision Holdings, Inc. Announces Fourth Quarter and Fiscal 2025 Earnings Release and Conference Call
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its fourth quarter and fiscal 2025 financial results before the market opens on Wednesday, March 4, 2026, and will host a confer…
Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, Provides 2026 Guidance
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its fourth-quarter and full-year 2025 financial results. “We didn’…
GenSight Biologics Bolsters Regulatory Leadership in US and Europe with Two Senior Appointments
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced finan…
Glaukos Announces Fourth Quarter and Full Year 2025 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, today announced finan…
FDA Expands U.S. Age Indication for EVO ICL as Long-Term Safety Data Reinforces Market Shift Away From Laser Vision Correction
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the U.S. Food and Drug Administrati…
Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
GENEVA–(BUSINESS WIRE)–Alcon Launches TOTAL30 Multifocal for Astigmatism, the World’s Only Monthly Multifocal Toric Contact Lens with Water Gradient Technology
Optometry Practices Elevate Patient Experience with RevolutionEHR’s Integrated, Modernized Patient Portal
SAN DIEGO–(BUSINESS WIRE)– #ONCCompliant–RevolutionEHR launches a modern, compliance-first patient portal that streamlines scheduling, billing, messaging, and records for optometry practices.
Warby Parker to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the fourth quarter and year ended December 31, 2025 will be releas…
iVeena Delivery Systems Announces First Patient Dosed in Phase 1 Study of IVMED-85 in Healthy Adult Volunteers
SALT LAKE CITY–(BUSINESS WIRE)–iVeena Delivery Systems, Inc. (“iVeena”), a clinical-stage ophthalmology company developing novel pharmacologic therapies for refractive eye diseases, today announced that the first participant has been dosed in its Pha…
Stanton Optical Celebrates Grand Opening of Four Store-in-Store Locations Inside Staples Stores
FRAMINGHAM, Mass. & DELRAY BEACH, Fla.–(BUSINESS WIRE)–Now Optics, parent company of Stanton Optical, and Staples today announced the grand opening of the first four “store-in-store” Stanton Optical locations inside select Staples stores in the Phila…
Stoke Therapeutics Announces First Patient Dosed in Phase 1 Study of STK-002, a Potential Disease-Modifying Medicine for the Treatment of Autosomal Dominant Optic Atrophy (ADOA)
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced that the first patient has been dosed in t…
NaphCare Supports ADA Compliance in Arizona Department of Corrections, Rehabilitation and Reentry Facilities
BIRMINGHAM, Ala.–(BUSINESS WIRE)–NaphCare, a leading correctional healthcare provider, commends the Arizona Department of Corrections, Rehabilitation and Reentry (ADCRR) on the resolution between the US Department of Justice (DOJ) and ADCRR over Titl…
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
PARIS–(BUSINESS WIRE)–Regulatory News: The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing i…
Warby Parker Appoints Adrian Mitchell as Chief Financial Officer
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY), a direct-to-consumer lifestyle brand focused on vision for all, today announced the appointment of Adrian Mitchell as Chief Financial Officer, effective February 10, 2026. His appointment stren…
La mayor planta de Menicon en Malasia comienza la producción comercial
NAGOYA, Japón–(BUSINESS WIRE)–Menicon Co., Ltd. tiene el placer de anunciar que su nueva planta de fabricación en Kedah, Malasia, ha iniciado la producción comercial. La planta reafirma el compromiso que Menicon mantiene desde hace tiempo con la exce…
Menicon马来西亚最大工厂开启商业化生产
日本名古屋–(BUSINESS WIRE)–(美国商业资讯)– Menicon Co., Ltd.欣然宣布，其位于马来西亚吉打州的新生产基地已开启商业化生产。该工厂强化了Menicon长期以来在卓越技术、严苛品质及稳定全球隐形眼镜供应方面的承诺。 这家新开业的马来西亚工厂是Menicon迄今为止规模最大的生产基地，专门用于生产日抛隐形眼镜。 全球日抛镜片需求持续攀升，而行业普遍面临供应限制，在此背景之下，Menicon进行了大规模资本投入以扩大产能，尽管新冠疫情带来诸多不确定性，公司仍坚定推进…
Menicons größtes Werk in Malaysia nimmt die kommerzielle Produktion auf
NAGOYA, Japan–(BUSINESS WIRE)–Menicon Co., Ltd. freut sich bekannt zu geben, dass sein neues Produktionswerk in Kedah, Malaysia, die kommerzielle Produktion aufgenommen hat. Das Werk unterstreicht Menicons langjähriges Engagement für technologische E…